证券记录 · 已归档季度
PEN
Penumbra, Inc. · Healthcare · Medical - Devices
14被追踪持有人
—Δ持有人
5.82M持有股份
$1.05B报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 116 | -12 | 22.38M | $7.07B | +3 | −14 |
| Q1 2026 | 130 | +2 | 22.22M | $7.29B | +14 | −13 |
| Q4 2025 | 129 | +2 | 30.57M | $9.51B | +3 | — |
| Q3 2025 | 22 | -2 | 23.38M | $5.92B | — | −3 |
| Q2 2025 | 22 | +3 | 20.19M | $5.18B | +3 | — |
| Q1 2025 | 16 | 0 | 6.15M | $1.64B | +1 | −1 |
| Q4 2024 | 16 | +2 | 5.72M | $1.36B | +2 | — |
| Q3 2024 | 13 | -1 | 4.72M | $917.01M | — | −1 |
| Q2 2024 | 14 | — | 5.82M | $1.05B | — | — |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 3.03M | — | $544.51M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 3.03M | — | $544.51M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (被动) | 644.32K | — | $115.99M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 644.32K | — | $115.99M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Baillie Gifford ✦ | 614.86K | — | $110.66M | 0.1% | n/c | 1 | SEC ↗ |
| 6 | Baillie Gifford ✦ | 614.86K | — | $110.66M | 0.1% | n/c | 1 | SEC ↗ |
| 7 | Baillie Gifford ✦ | 614.86K | — | $110.66M | 0.1% | n/c | 1 | SEC ↗ |
| 8 | Baillie Gifford ✦ | 614.86K | — | $110.66M | 0.1% | n/c | 1 | SEC ↗ |
| 9 | Capital World Investors ✦ | 544.99K | — | $98.08M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Norges Bank ✦ (被动) | 344.81K | — | $62.06M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 178.41K | — | $31.28M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 178.41K | — | $31.28M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 178.41K | — | $31.28M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Marshall Wace ✦ | 107.69K | — | $19.38M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Marshall Wace ✦ | 107.69K | — | $19.38M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Millennium Management ✦ | 105.17K | — | $18.93M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Renaissance Technologies ✦ | 99.70K | — | $17.94M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 69.02K | — | $12.42M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 69.02K | — | $12.42M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | PRIMECAP Management ✦ | 39.93K | — | $7.19M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Bridgewater Associates ✦ | 19.40K | — | $3.49M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Gotham Asset Management ✦ | 17.11K | — | $3.08M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | D. E. Shaw & Co. ✦ | 8.57K | — | $1.54M | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 479 持有人, 33.44M 股份, $10.70B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
Aug 13
SC 13G — BARCLAYS PLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据